India  

Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death

Video Credit: Wochit News - Duration: 00:25s - Published
Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death

Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death

Business Insider reports that a coronavirus vaccine my not be ready until the end of 2021, according to Roche, the world's second-largest pharmaceutical company.

He explained "According to the most likely scenario, we will not have a vaccination before the end of next year." Instead, Severin Schwan, chief executive of Roche, says that the public could have access to antibody tests sooner.


You Might Like

Related news from verified sources

Drug touted by Trump to treat COVID-19 linked to higher death risk: study

The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking...
Reuters India - Published

WHO halts hydroxychloroquine trials after study shows drug may increase risk of death

"The authors reported that among patients receiving the drug, when used alone or with a macrolide,...
DNA - Published

U.S. veterans agency has given hydroxychloroquine to 1,300 coronavirus patients

The U.S. Department of Veterans Affairs (VA) has treated 1,300 coronavirus patients with the malaria...
Reuters India - Published


Related videos from verified sources

Study focuses on risks of breast cancer after pre-invasive disease [Video]

Study focuses on risks of breast cancer after pre-invasive disease

In a breakthrough study, researchers found that the women who are diagnosed with ductal carcinoma in situ (known as DCIS) during breast screening go on to experience higher risks of developing breast..

Credit: ANI     Duration: 01:12Published
World Health Organization Halts Trials Of Hydroxychloroquine [Video]

World Health Organization Halts Trials Of Hydroxychloroquine

The World Health Organization announced they are temporarily suspending clinical trials of hydroxychloroquine. The controversial drug has been used as an experimental coronavirus treatment for the..

Credit: Wochit     Duration: 00:38Published
Explained: Why WHO suspended hydroxychloroquine trials | Covid-19 [Video]

Explained: Why WHO suspended hydroxychloroquine trials | Covid-19

The World Health Organization has temporarily halted trials on hydroxychloroquine due to safety concerns. According to a study by The Lancet, patients given HCQ had higher death rates than those not on..

Credit: HT Digital Content     Duration: 05:09Published